Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma

Leuk Lymphoma. 2009 Feb;50(2):303-5. doi: 10.1080/10428190802617805.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Humans
  • Immunotherapy*
  • Injections, Intralesional
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / immunology*
  • Lymphoma, Follicular / pathology
  • Lymphoma, Follicular / surgery
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / immunology*
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Staging
  • Positron-Emission Tomography
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab